A detailed history of Birch Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Birch Capital Management, LLC holds 10,147 shares of ABBV stock, worth $1.67 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
10,147
Previous 10,649 4.71%
Holding current value
$1.67 Million
Previous $1.83 Million 9.69%
% of portfolio
1.0%
Previous 0.97%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $82,247 - $100,063
-502 Reduced 4.71%
10,147 $2 Million
Q1 2024

Apr 11, 2024

SELL
$159.82 - $182.1 $309,890 - $353,091
-1,939 Reduced 15.4%
10,649 $1.94 Million
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $48,985 - $55,169
-356 Reduced 2.75%
12,588 $1.95 Million
Q4 2021

Jan 06, 2022

SELL
$107.43 - $135.93 $80,357 - $101,675
-748 Reduced 5.46%
12,944 $1.75 Million
Q3 2021

Oct 05, 2021

SELL
$106.4 - $120.78 $47,560 - $53,988
-447 Reduced 3.16%
13,692 $1.48 Million
Q1 2021

Apr 05, 2021

SELL
$102.3 - $112.62 $101,379 - $111,606
-991 Reduced 6.55%
14,139 $1.53 Million
Q3 2020

Oct 06, 2020

SELL
$85.91 - $100.83 $64,260 - $75,420
-748 Reduced 4.71%
15,130 $1.33 Million
Q2 2020

Jul 02, 2020

SELL
$73.37 - $98.18 $155,030 - $207,454
-2,113 Reduced 11.74%
15,878 $1.56 Million
Q1 2020

Apr 02, 2020

SELL
$64.5 - $97.79 $99,330 - $150,596
-1,540 Reduced 7.88%
17,991 $1.37 Million
Q4 2019

Jan 27, 2020

BUY
$72.13 - $90.25 $1.41 Million - $1.76 Million
19,531 New
19,531 $1.73 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Birch Capital Management, LLC Portfolio

Follow Birch Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birch Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Birch Capital Management, LLC with notifications on news.